REQUEST A DEMO
Total
USD $0.00
Search more companies

Solpharma Sp. z o.o. (Poland)

Main Activities: Marketing Research and Public Opinion Polling
Full name: Solpharma Sp. z o.o. Profile Updated: June 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Solpharma Sp. z o.o. is an enterprise located in Poland, with the main office in Elizowka. The enterprise currently operates in the Marketing Research and Public Opinion Polling sector. The enterprise was incorporated on October 09, 2019. In 2023, the company reported a net sales revenue increase of 10.84%. Its’ total assets recorded a growth of 108.64%. In, 2023, the company’s net profit margin increased by 6.27%.

Headquarters
Ul. Szafranowa 6
Elizowka; Lubelskie; Postal Code: 21-003

Contact Details: Purchase the Solpharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Solpharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Solpharma Sp. z o.o. report to view the information.
Incorporation Date:
October 09, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Solpharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
10.84%
Total operating revenue
13.21%
Operating profit (EBIT)
93.16%
Net Profit (Loss) for the Period
93.13%
Total assets
108.64%
Total equity
-5.21%
Operating Profit Margin (ROS)
6.27%
Net Profit Margin
6.27%
Return on Equity (ROE)
-70.94%
Quick Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?